V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20162965 | 20062879 | 1.73 | 80 | Curative (C) | 2018-03-01 | 2018-03-03 | ECX | 2 | N | ECX | 101806206 |
| 20162969 | 20062880 | 1.7 | 68.9 | Palliative (P) | 2016-09-27 | 2016-09-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101829009 |
| 20162971 | 20062881 | 1.69 | 99.1 | Palliative (P) | 2016-10-26 | 2016-11-03 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100855644 |
| 20162977 | 20062882 | 1.66 | 70.5 | Palliative (P) | null | 2018-06-13 | ECX | null | N | CAPECITABINE + GEMCITABINE | 100464176 |
| 20162978 | 20062883 | 1.74 | 62.1 | Neo-adjuvant (N) | 2017-06-26 | 2017-06-28 | ECX | 02 | N | ECX | 100182042 |
| 20162982 | 20062884 | 1.63 | 93 | Neo-adjuvant (N) | 2018-05-05 | 2018-05-17 | ECX | N | N | ECX | 101849557 |
| 20162995 | 20062885 | 1.7 | 60 | Palliative (P) | 2017-10-07 | 2017-11-26 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101192329 |
| 20162997 | 20062886 | 1.59 | 79.7 | Adjuvant (A) | 2017-09-07 | 2017-10-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101632403 |
| 20162998 | 20062887 | 1.6 | 52.7 | Neo-adjuvant (N) | 2016-07-20 | 2016-08-02 | ECX | N | N | ECX | 101613004 |
| 20163000 | 20062888 | 1.8 | 77.4 | Neo-adjuvant (N) | 2019-08-25 | 2019-09-21 | ECX | null | N | ECX | 101804834 |
| 20163004 | 20062889 | 1.81 | 62 | Adjuvant (A) | 2017-09-29 | 2017-10-10 | ECX | N | N | ECX | 100937158 |
| 20163005 | 20062890 | 1.84 | 41 | Palliative (P) | 2018-09-03 | 2018-09-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100998779 |
| 20163018 | 20062891 | 1.77 | 90.15 | Curative (C) | 2017-02-14 | 2017-03-20 | ECX | N | N | ECX | 101767407 |
| 20163019 | 20062892 | 1.55 | 59 | Palliative (P) | 2019-01-13 | 2019-01-20 | ECX | N | N | CAPECITABINE + GEMCITABINE | 100726107 |
| 20163025 | 20062893 | 1.75 | 77.1 | null | 2018-01-02 | 2018-01-15 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100444762 |
| 20163026 | 20062894 | 1.68 | 58.6 | Palliative (P) | 2017-12-24 | 2017-12-24 | ECX | 2 | N | ECX | 100968247 |
| 20163031 | 20062895 | 1.72 | 63 | Adjuvant (A) | 2018-03-13 | 2018-03-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101812516 |
| 20163039 | 20062896 | 1.78 | 76.1 | Adjuvant (A) | 2019-06-04 | 2019-07-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101227900 |
| 20163041 | 20062897 | 1.61 | 66.1 | Palliative (P) | 2018-03-24 | 2018-04-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100230861 |
| 20163047 | 20062898 | 1.62 | 67.65 | Adjuvant (A) | 2018-05-30 | 2018-06-03 | ECX | 2 | N | ECX | 100265449 |
| 20163048 | 20062899 | 1.66 | 71.7 | Neo-adjuvant (N) | 2017-01-31 | 2017-01-31 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100067371 |
| 20163049 | 20062900 | 1.72 | 72.25 | null | 2018-05-16 | 2018-05-17 | ECX | N | N | ECX | 101147593 |
| 20163050 | 20062901 | 1.75 | 88.9 | Neo-adjuvant (N) | 2016-07-24 | 2016-07-24 | ECX | 02 | N | ECX | 100722153 |
| 20163054 | 20062902 | 1.65 | 61 | Palliative (P) | null | 2017-01-28 | ECX | null | N | ECX | 100355061 |
| 20163055 | 20062903 | 1.78 | 86 | Adjuvant (A) | 2018-09-06 | 2018-09-14 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101663287 |
| 20163056 | 20062904 | 1.6 | 52.8 | Adjuvant (A) | 2016-03-21 | 2016-04-05 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101101505 |
| 20163060 | 20062905 | 1.65 | 60.7 | Curative (C) | 2016-04-09 | 2016-04-28 | ECX | N | N | CAPECITABINE + GEMCITABINE | 101626127 |
| 20163066 | 20062906 | 1.59 | 79 | Neo-adjuvant (N) | 2017-07-04 | 2017-07-06 | ECX | N | N | ECX | 101189034 |
| 20163074 | 20062907 | 1.75 | 74.7 | Neo-adjuvant (N) | 2017-05-10 | 2017-05-10 | ECX | N | N | ECX | 101630582 |
| 20163075 | 20062908 | 1.67 | 66.4 | null | 2019-04-24 | 2019-04-24 | ECX | 02 | N | ECX | 100765059 |
| 20163076 | 20062909 | 1.57 | 51.1 | Palliative (P) | 2017-04-18 | 2017-04-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100222654 |
| 20163083 | 20062910 | null | null | Neo-adjuvant (N) | 2016-07-20 | 2016-07-20 | ECX | 02 | N | ECX | 101161557 |
| 20163084 | 20062911 | 1.77 | 81.8 | null | 2016-12-28 | 2016-12-29 | Gemcitabine + Capecitabine | N | N | ECX | 101538269 |
| 20163085 | 20062912 | null | 76.2 | Adjuvant (A) | null | 2018-07-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101588575 |
| 20163086 | 20062913 | 1.63 | 55.45 | Palliative (P) | 2016-02-22 | 2016-02-29 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101517349 |
| 20163089 | 20062914 | 1.71 | 67.7 | Curative (C) | 2017-12-28 | 2018-01-05 | ECX | N | N | ECX | 101346410 |
| 20163093 | 20062915 | 1.66 | 65.1 | Palliative (P) | 2019-05-19 | 2019-05-23 | ECX | 02 | N | ECX | 101649362 |
| 20163096 | 20062916 | 1.71 | 63.2 | Neo-adjuvant (N) | 2019-01-19 | 2019-02-15 | ECX | null | N | ECX | 100013478 |
| 20163098 | 20062917 | 1.62 | 68.9 | Palliative (P) | 2019-12-20 | 2019-12-20 | ECX | N | N | ECX | 101853064 |
| 20163100 | 20062918 | 1.89 | 58.9 | Curative (C) | 2019-01-29 | 2019-02-12 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101780033 |
| 20163103 | 20062919 | 1.71 | 54.5 | Palliative (P) | 2017-11-22 | 2017-11-22 | ECX | N | N | ECX | 101341032 |
| 20163106 | 20062920 | 1.52 | 54.3 | Palliative (P) | 2018-08-31 | 2018-09-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100389266 |
| 20163110 | 20062921 | 1.82 | 64.4 | null | 2017-12-23 | 2018-01-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101783739 |
| 20163114 | 20062922 | 1.63 | 81.6 | Palliative (P) | 2018-06-21 | 2018-06-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100057900 |
| 20163123 | 20062923 | 1.6 | 63.4 | Curative (C) | 2018-10-20 | 2018-11-01 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 101119886 |
| 20163139 | 20062924 | 1.73 | 67 | Adjuvant (A) | 2019-10-20 | 2019-10-20 | Gemcitabine + Capecitabine | Y | null | CAPECITABINE + GEMCITABINE | 101379075 |
| 20163142 | 20062925 | 1.82 | 72.3 | Palliative (P) | 2019-11-24 | 2019-11-24 | Gemcitabine + Capecitabine | 02 | Y | CAPECITABINE + GEMCITABINE | 101559115 |
| 20163145 | 20062926 | 1.75 | 77.1 | Curative (C) | 2019-11-24 | 2019-11-24 | ECX | 2 | N | ECX | 101634505 |
| 20163149 | 20062927 | 1.7 | 102.2 | Palliative (P) | 2016-04-30 | 2016-05-20 | ECX | N | N | ECX | 100786055 |
| 20163151 | 20062928 | 1.63 | 48 | null | 2016-05-21 | 2016-06-12 | Gemcitabine + Capecitabine | N | N | ECX | 101329100 |